Logo

research consortium

With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer 'Drug Discovery Enterprise'
Premium

The MOSAIC research coalition brings together Owkin, NanoString, and European and US institutions to create a massive spatial omics dataset in pursuit of novel cancer biomarkers

Owkin, NanoString Technologies Launch $50M Spatial Omics Research Program for Cancer Research

The companies have assembled a coalition of research institutions in the US and Europe to apply spatial omics to biomarker and drug discovery.

Massive Bio to Provide AI Analytics to Precision Cancer Consortium

The bioinformatics firm hopes to help the coalition of biopharmaceutical companies improve oncology clinical trial matching and access to NGS testing.

NIH Funds $140M Program to Catalog Somatic Mosaicism in Humans

Supported by the institute's Common Fund, the program aims to accelerate research on human development, aging, and disease.

Genomenon Partners With Neurodevelopmental Disease Groups on Drug Development

The Ann Arbor, Michigan-based bioinformatics company will provide AI-driven genomic data analysis in search of precision treatments for several rare pediatric disorders.

Oct 7, 2022

Center for Multiomic Human Brain Atlas to Tackle Methylation, Gene Expression for $500M NIH Project
Premium

May 6, 2022

Rady Children's to Launch Consortium for Rapid Whole-Genome Sequencing of Newborns

May 2, 2022

Rancho Biosciences Launches Single-Cell Data Science Consortium With Pharma Firms

Feb 8, 2022

Lifebit Counting on New UK Partnerships to Develop, Validate Federated Data Model
Premium

Jan 10, 2022

CRISPR-IL Consortium Hopes AI Can Improve Accuracy, Efficiency of Gene Editing
Premium

Dec 16, 2021

Seven Bridges Genomics to Foster Partnerships Between Health Systems, Pharmas With New Subsidiary
Premium

Nov 10, 2021

Israeli Government Extends CRISPR-IL Consortium With $14.5M in New Funding

Aug 18, 2021

Data Privacy Concerns Top of Mind for Planned African Genome Project
Premium

Jul 28, 2021

AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project
Premium

Jun 15, 2021

Autism Sharing Initiative Brings Federated Data Model to Research, Clinical Care
Premium

Apr 30, 2021

Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients
Premium

Mar 2, 2021

NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program

Feb 16, 2021

LifeArc Providing £5M for COVID-19 Study on Genomics of Severe Disease

Feb 9, 2021

European Project Sets Out to Harness Genomics Data, AI to Create New Predictive Tools
Premium

Feb 8, 2021

Sophia Genetics, Spanish Lung Cancer Group Team up to Predict Lung Cancer Treatment Response

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Dec 1, 2020

Canadian Consortium Launches COVID Cloud to Support Molecular Research

Aug 28, 2020

UK Consortium Wins £6.5M From Government to Study SARS-CoV-2 Immune Response

May 1, 2020

CDC Leads Public-Private Consortium to Coordinate SARS-CoV-2 Genome Sequencing in US

Apr 21, 2020

New York COVID-19 Genomics Research Network Coalesces to Battle Pandemic

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.